| Model Number |
9-ACP2-010-025 |
| Medical Device Problem Codes |
Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Pericardial Effusion (3271)
|
| Date of Event |
03/06/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that on (b)(6) 2026, a 25mm amplatzer amulet was implanted using an 12f delivery system.Prior to the amulet implant, a trivial pericardial effusion was noted.A transseptal puncture was performed in an inferior/mid location, with a reported left atrial pressure of 11 mmhg at the time of the procedure.During the procedure, heparin was administered at a dose of 15,000 units, achieving an activated clotting time (act) of 310 seconds.The device required one repositioning during implantation, with no multiple wire or delivery sheath exchanges reported and wire position not changing between pulmonary veins.Protamine was administered directly after sheath removal.On (b)(6) 2026, it was discovered that the patient experienced pericardial effusion.The user reported the belief that the pericardial effusion was caused by the amulet device.
|
| |
|
Additional Manufacturer Narrative
|
|
It is unknown if the device is returning for analysis.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Event or Problem Description
|
|
It was reported that on (b)(6) 2026, a 25mm amplatzer amulet was implanted using an 12f delivery system.Prior to the amulet implant, a trivial pericardial effusion was noted.A transseptal puncture was performed in an inferior/mid location, with a reported left atrial pressure of 11mmhg at the time of the procedure.During the procedure, heparin was administered at a dose of 15,000 units, achieving an activated clotting time (act) of 310 seconds.The device required one repositioning during implantation, with no multiple wire or delivery sheath exchanges reported and wire position not changing between pulmonary veins.Protamine was administered directly after sheath removal.On (b)(6) 2026, it was discovered that the patient experienced pericardial effusion.The user reported the belief that the pericardial effusion was caused by the amulet device.
|
| |
|
Additional Manufacturer Narrative
|
|
An event of pericardial effusion post procedure was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information available, the cause of the reported pericardial effusion cannot be conclusively determined.The reported serious injury/illness/impairment were due to case-specific circumstances as no further intervention or treatment was performed.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.Codes removed:
health effect-clinical code:
medical device problem code: 2993.
|
| |
|
Search Alerts/Recalls
|